October 20, 2017 8:22 PM ET

Biotechnology

Company Overview of Chantal Pharmaceutical

Key Executives for Chantal Pharmaceutical

NameBoard RelationshipsTitleAge
Chantal Burnison 7 RelationshipsChairman of Board and CEO66
Marc Dworkin 3 RelationshipsPresident70
Yvette Lamprecht No RelationshipsChief Financial Officer49
Polly Bergen 7 RelationshipsChief Operating Officer and Director86
Joseph Dekama No RelationshipsExecutive Vice President and President - Chantal Skin Care Corporation77

Chantal Pharmaceutical Board Members*

NameBoard RelationshipsPrimary CompanyAge
Chantal Burnison 7 RelationshipsChantal Pharmaceutical66
Polly Bergen 7 RelationshipsChantal Pharmaceutical86
George Goldstein 7 RelationshipsChantal Pharmaceutical84
Robert G. Pinco Esq. 9 RelationshipsCygene Laboratories Inc.73
Gilbert D. Raker 11 RelationshipsWyngate Capital, LLC73
View All Board Members

Chantal Pharmaceutical Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary$290.0K
290.0K
390.5K
Bonus
Not meaningful
Total Short Term Compensation$290.0K
290.0K
487.0K
Total Value of Options
17.9M
Compensation as of Fiscal Year
Chantal Pharmaceutical CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Verseon Corporation Appoints Robert W. Karr as Non-Executive Class II Director
October 20, 2017 6:00 AM ET
Neurocrine Biosciences, Inc. Announces Management Changes
October 19, 2017 9:26 PM ET
AveXis, Inc. Announces Management Changes
October 19, 2017 8:58 PM ET
Peregrine Pharmaceuticals, Inc. and Avid Bioservices, Inc. Appoint Mark R. Bamforth as an Independent Member of the Board of Directors
October 19, 2017 12:05 PM ET
Cellect Biotechnology Ltd. Announces Executive Changes
October 19, 2017 11:05 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Chantal Pharmaceutical, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.